Ellen Licking Email & Phone Number

San Francisco Bay Area

San Francisco Bay Area

San Jose, California, United States

Palo Alto, Ca

Palo Alto, California, United States

San Francisco Bay Area

- Editor and author of Ernst & Young's life sciences reports, including Progressions, Beyond borders, and Pulse- Developer of Ernst & Young's life sciences thought leadership- Active on social media including Twitter and EY's Life Sciences blog.- Areas of expertise: Life sciences business strategies, R&D, deal making and financing; digital health; product reimbursement.

Palo Alto, Ca

I'm currently freelancing (e.g. long-form articles, internal strategic analysis,blog posts) and developing content for healthcare related meetings, including PharmAsia Summit and the 2nd annual Real Endpoints Symposium. Topics of interest include R&D strategy, biopharma deal-making, and reimbursement/HEOR analyses. Skilled at external communications and social media strategies. I tweet about healthcare innovation (mostly) @EllenLicking.

As a contributing writer at EY, I helped identify and interview external sources for three life sciences reports: Progressions, Beyond borders and Pulse. I also developed or helped develop the main point of view for both Beyond borders and Pulse of the Industry and authored or edited the data-driven chapter for both reports. Finally, I assisted EY's marketing and communications team in conducting QR for both Beyond borders and Pulse and developing accompanying press releases.

Palo Alto, Ca

As a writer and analyst for Real Endpoints' new blog and advisory service, I created pointed analyses on emerging best practices related to the reimbursement of high priced specialty products, particularly new oncologics. I also developed content and marketing materials and recruited speakers for the inaugural Real Endpoints Symposium, a two-day meeting of payers, product makers, and providers discussing healthcare value and new product innovation.

Palo Alto, Ca

Senior level editor for FDC-Windhover, a division of Elsevier Science. Coordinates financial coverage related to biopharmaceutical industry and writes stories for multiple FDC and Windhover publications, including The Pink Sheet, The Pink Sheet Daily, Start-Up, In Vivo, and The In Vivo Blog.

Co-managed a team ofwriters and editors, with an eye to covering important biopharma financial and strategy news for monthly publications, START-UP & IN VIVO. Regular contributor to START-UP, IN VIVO and the IN VIVO Blog, writing and reporting in-depth features and a weekly licensing news column. Areas of coverage: emerging science; R&D strategy; deal-making trends; drug delivery.

Writer and editor for Business Week; regular contributor to the weekly "Developments To Watch" column; also authored in-depth features, special reports and cover length articles.

Biochemistry, Microbiology

Thesis: Genetic Regulation and Development of the Gram-Negative Myxococcus xanthus Teaching Assistant, Biochemistry Coursework outside.

M. Phil., Biochemistry

Activities and Societies: Green society I studied the enzyme phosphorylation in the Dept. of Biochemistry. In my spare time, I rowed crew.

Ba, Biochemistry

Activities and Societies: Phi Beta Kappa, Sigma Xi, Writing Associate (1989-1992), Teaching Assistant, Track and Field (1989, 1990, 1992).